Stimulant | Assessment point | Status of priming | HIV-1 positive | HIV negative | Community controls | ||||
Fe pos (Sgr I) n = 54 | Fe neg (Sgr II) n = 54 | Fe pos (Sgr III) | Fe neg (Sgr IV) | (Sgr V) | |||||
Category of ARI on follow up | Category of ARI on follow up |
|
|
| |||||
PT n = 38 | non-PT n = 16 | PT n = 10 | non-PT n = 44 | n = 30 | n = 50 | n = 40 | |||
PMA | En | Unpr | 1.2 ± 2.0‽‡ | 2.6 ± 2.1‽ | 2.4 ± 0.9‽ | 4.3 ± 1.2‽ | 1.6 ± 1.4‽ | 7.4 ± 1.2 | 8.6 ± 1.8 |
Pr | 1.6 ± 1.8 | 2.8 ± 1.3 | 10.4 ± 4.8† | 12.2 ± 6.8† | 1.8 ± 1.4 | 14.8 ± 4.2† | 18.6 ± 4.8† | ||
Fu | Unpr | 1.9 ± 2.1‽‡ | 3.2 ± 1.8‽ | 3.2 ± 1.2‽ | 4.4 ± 0.8‽ | NA | NA | NA | |
Pr | 9.1 ± 1.9†* | 12.4 ± 1.5†* | 11.2 ± 3.8† | 12.4 ± 6.1† | NA | NA | NA | ||
SAC | En | Unpr | 4.8 ± 2.6‽‡ | 8.4 ± 4.2‽ | 5.4 ± 3.6‽ | 7.8 ± 4.2‽ | 4.2 ± 2.9‽ | 72 ± 32.4 | 88 ± 22.4 |
Pr | 5.2 ± 3.2 | 9.6 ± 5.1 | 56 ± 12.8† | 134 ± 38.8† | 5.1 ± 3.8 | 134 ± 42.6† | 148 ± 32.6† | ||
Fu | Unpr | 7.2 ± 3.6‽ | 10.2 ± 4.1‽ | 8.6 ± 4.2‽ | 10.2 ± 5.4‽ | NA | NA | NA | |
Pr | 58.8 ± 20.2†* | 78 ± 16.2†* | 68 ± 12.8† | 144 ± 18.2† | NA | NA | NA |